ModivCare — Q3 2023 Earnings Presentation
36 slides from ModivCare's earnings presentation, Nov 3, 2023
Slide 1: Investor Presentation
Investor Presentation November 2023 © 2023 Modivcare® Inc. © 2023 Modivcare® 1 Inc.
Slide 2: Forward Looking Statements
Forward Looking Statements Certain statements contained in this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as “may,”
Slide 3: National Tech-Enabled Platform with Market-Leading Solutions
National Tech-Enabled Platform with Market-Leading Solutions Supportive Integrated Supportive Care Revenue Adj. EBITDA Care Addressing the Social Determinants of Health (SDoH) $2.7B (1) $214M (1) Transportation Personal Care Remote Monitoring Largest provider of Leading provider of in-home Leading p
Slide 4: Evolution into Leading Provider of Holistic Supportive Care
Evolution into Leading Provider of Holistic Supportive Care National Broker of Expansion of Services Improved Health One Modivcare NEMT Services to Address SDoH Outcomes at Scale PCS 24M 34M $2.7B Lives Managed Lives Managed Revenue RPM $1.5B 15K 200+ Annual Revenue Caregivers RPM Device Options SDo
Slide 5: Seasoned Operating Leaders
Seasoned Operating Leaders Heath Sampson Ilias Simpson Anne Bailey Barbara Gutierrez Chief Executive Officer President, Modivcare Mobility President, Modivcare Home Chief Financial Officer Jessica Kral Henry “Enrique” Toledo Jeff Bennett Seth Ravine Chief Information Officer Chief People Officer Chi
Slide 6: Investment Highlights
Investment Highlights 1 Solutions Address Needs of a Large, Growing Complex & Chronic Population 2 Leading Positions in Attractive End-Markets with Differentiated Value Proposition 3 Significant Market Opportunity to Pursue Profitable Growth in $150B Whitespace 4 Leveraging Tech to Realize Efficienc
Slide 7: Financial Summary
Financial Summary | | [| modivcare
Slide 8: Financial Overview
Financial Overview Business Mix (1) Financial Performance ($ in millions) NEMT PCS RPM RPM $2,702 3% $2,504 PCS $1,997 26% Revenue $1,369 71% NEMT 2020 2021 2022 LTM 9/30/23 RPM $222 $214 11% $205 PCS $169 Adj. EBITDA 30% 59% NEMT 2020 2021 2022 LTM 9/30/23 Note: See Appendix for presentation of Non
Slide 9: 3Q 2023 Financial Review
3Q 2023 Financial Review ($ in millions, except per share) Q3 2022 Q2 2023 Q3 2023 YoY (% ) QoQ (% ) 3Q 2023 Financial Results Modivcare Consolidated ▪ Top-line growth driven by growth from NEMT (+6% y/y), PCS (+6% y/y), Revenue $647.8 $699.1 $686.9 6.0% (1.7%) and RPM (+5% y/y) Adjusted EBITDA $51.
Slide 10: NEMT | 3Q 2023 Highlights
NEMT | 3Q 2023 Highlights ($ in millions, except per share) Q3 2022 Q2 2023 Q3 2023 YoY (%) QoQ (%) Commentary Service Revenue, net $459.8 $497.0 $486.0 5.7% (2.2%) ▪ Revenue increased 6% YoY driven by a 10% increase in paid trips, Service Expense, Purchased Services 340.1 377.2 363.6 6.9% (3.6%) pa
Slide 11: NEMT | Initiatives to Optimize Cost Structure
NEMT | Initiatives to Optimize Cost Structure Omni-Channel Member Engagement Multi-Modal Network Digital Customer Integration Enhanced products including: ✓ Mass transit, Mileage reimbursement ✓ App ✓ IVR and Rideshare modes ✓ 360 Member Profile Underlying Initiatives ✓ Web ✓ Text ✓ Trip Auto-Assign
Slide 12: PCS | 3Q 2023 Highlights
PCS | 3Q 2023 Highlights ($ in millions, except per share) Q3 2022 Q2 2023 Q3 2023 YoY (%) QoQ (%) Commentary Service Revenue, net $169.2 $180.3 $180.0 6.4% (0.2%) ▪ Revenue increased 6% YoY driven by 2% higher Hours and 4% growth Revenue per Hour Service Expense $132.7 $138.5 $143.1 7.8% 3.3% Gross
Slide 13: RPM | 3Q 2023 Highlights
RPM | 3Q 2023 Highlights ($ in millions, except per share) Q3 2022 Q2 2023 Q3 2023 YoY (%) QoQ (%) Commentary Service Revenue, net $18.8 $19.2 $19.8 5.4% 3.0% ▪ Revenue increased 5% YoY, driven by continued referrals momentum, market expansion, and new E3 sales which yielded Service Expense $6.8 $6.
Slide 14: 3Q 2023 Cash Position Bridge
3Q 2023 Cash Position Bridge ($ in millions) $15 $0 ($1) ($9) $51 ($11) $8 $7 ($44) 2Q23 Cash & Cash (+) Adj. EBITDA (+/-) Contract Payables / (-) Other NWC (-) Cash Interest (-) Capex (-) Restructuring / (+/-) Draw/Paydown 3Q23 Cash & Cash Equivalents Receivables Settlements / Integration on Revolv
Slide 15: 3Q 2023 Capital Structure
3Q 2023 Capital Structure ($ in millions) 6/30/2023 9/30/2023 Commentary Cash & Cash Equivalents $7 $8 ▪ 3Q23 free cash flow was $45 million(2) driven by cash Revolving Credit Facility due 2027 ($325) 127 83 flow from operations of $54 million less capital 5.875% Senior Unsecured Notes due 2025 500
Slide 16: Maintained 2023 Guidance
Maintained 2023 Guidance ($ in millions) Consolidated Metrics Guidance Revenue $2,750 – $2,800 Adjusted EBITDA $200 – $210 % Adj. EBITDA Margin 7.1% – 7.6% Note: 2023 outlook excludes impact of M&A © 2023 Modivcare® Inc. 16
Slide 17: Appendix
Appendix
Slide 18: NEMT | Quarterly Performance
NEMT | Quarterly Performance Financial Performance Key Metrics 600 10000 20 Revenue ($mm) Adj. EBITDA Margin Trips (000s) Gross Profit per Trip ($) 9000 8,735 8,824 18 $497 8,202 500 $486 8,046 $469 8000 7,831 7,807 16 $460 $459 $449 7,111 $401 7000 14 400 6000 12 10% 10% $9.68 $9.57 300 9% 5000 $9.
Slide 19: PCS | Quarterly Performance
PCS | Quarterly Performance Financial Performance Key Metrics Revenue ($mm) Adj. EBITDA Margin 7500 Hours (000s) Revenue per Hour ($) 50 190 $180 $180 180 $176 45 $174 6,995 7000 6,933 $169 6,836 6,842 170 6,824 $163 6,705 40 $160 13% 160 6,535 6500 11% 11% 35 150 10% 10% 10% 9% 140 30 6000 $25.73 $
Slide 20: RPM | Quarterly Performance
RPM | Quarterly Performance Financial Performance Key Metrics 25 Revenue ($mm) Adj. EBITDA Margin Avg. Monthly Members (000s) Revenue PMPM ($) 50 250 247 236 240 235 45 $20 230 20 $19 $19 $19 $19 203 $17 200 40 38% 15 169 $14 36% 36% 35 35% 150 35% 34% 30 10 33% $27.33 $27.50 $27.19 $26.72 $26.54 $2
Slide 21: Medicaid Redetermination
Medicaid Redetermination Renewal and Disenrollment Rate by State (1) 10.0M 35% # Disenrolled % Renewals Disenrolled Terminated for Procedural Reasons Determined Ineligible Coverage Renewed 50 Reporting States & DC Texas Georgia 18.2M 65% Oklahoma # Eligibility Renewed % Eligibility Renewed Kansas 50
Slide 22: Modivcare Redetermination Update
Modivcare Redetermination Update ▪ Modivcare is tracking better than national redetermination rates and remains closely aligned with our customer’s estimates ▪ Redetermination impact is eased through continuous contract wins YTD Redetermination Membership Impact YTD Redetermination Progress vs. Proj
Slide 23: NEMT | Strategic Shift in Contract Mix
NEMT | Strategic Shift in Contract Mix Contract Structure Medicaid Revenue Mix (1) Shared Risk Full Risk FFS Full Risk 89% ▪ Fixed per member per month (“PMPM”) payments 86% 83% 83% ▪ Revenue model: Membership X Contractual PMPM 13% 11% 12% 13% ▪ Gross margin is impacted by varying unit cost and uti
Slide 24: NEMT | Illustrative Contract Structures
NEMT | Illustrative Contract Structures FFS Key Attributes Revenue PMPM – Contractual prepaid per Full 1 member fee to manage NEMT services 3 Risk 1 4 Shared Risk True-Up – True-up of contractual prepaid PMPM fee, if actual costs incurred 2 deviate outside of predefined boundaries, Revenue Mix Prepa
Slide 25: NEMT | Working Capital Normalization
NEMT | Working Capital Normalization Contract Payables, Net of Receivables Background of Contract Payables / Receivables $300 Contract Payables / Receivables ▪ Contract Payables primarily represent overpayments and liability reserves on certain risk $250 corridor, profit rebate and reconciliation co
Slide 26: Supplemental Data
Supplemental Data | | [| modivcare
Slide 27: NEMT | Key Statistical and Financial Data
NEMT | Key Statistical and Financial Data Modivcare Inc. Unaudited Key Statistical and Financial Data (in thousands) Year Year Quarterly Results - 2021 ended Quarterly Results - 2022 ended Quarterly Results - 2023 NEMT Segment Q1 Q2 Q3 Q4 2021 Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3 Service revenue, net 343,416 3
Slide 28: PCS | Key Statistical and Financial Data
PCS | Key Statistical and Financial Data Modivcare Inc. Unaudited Key Statistical and Financial Data (in thousands) Year Year Quarterly Results - 2021 ended Quarterly Results - 2022 ended Quarterly Results - 2023 Personal Care Segment Q1 Q2 Q3 Q4 2021 Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3 Service revenue, net 1
Slide 29: RPM | Key Statistical and Financial Data
RPM | Key Statistical and Financial Data Modivcare Inc. Unaudited Key Statistical and Financial Data (in thousands) Year Year Quarterly Results - 2021 ended Quarterly Results - 2022 ended Quarterly Results - 2023 RPM Segment Q1 Q2 Q3 Q4 2021 Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3 Service revenue, net 1,564 16,05
Slide 30: Corporate and Other | Key Statistical and Financial Data
Corporate and Other | Key Statistical and Financial Data Modivcare Inc. Unaudited Key Statistical and Financial Data (in thousands) Year Year Quarterly Results - 2021 ended Quarterly Results - 2022 ended Quarterly Results - 2023 Corporate and Other Segment Q1 Q2 Q3 Q4 2021 Q1 Q2 Q3 Q4 2022 Q1 Q2 Q3
Slide 31: Non-GAAP Reconciliations
Non-GAAP Reconciliations | | [| modivcare
Slide 32: Non-GAAP Reconciliation
Non-GAAP Reconciliation Reconciliation of Adjusted EBITDA of Modivcare (dollars in thousands) FY 2019 FY 2020 1Q21 2Q21 3Q21 4Q21 FY 2021 1Q22 2Q22 3Q22 4Q22 FY2022 1Q23 2Q23 3Q23 LTM 3Q23 Net income (loss) ($4,953) $89,614 $18,840 $13,672 ($7,572) ($31,525) ($6,585) $318 $3,328 ($28,505) ($6,947) (
Slide 33: Non-GAAP Reconciliation | FY2022
Non-GAAP Reconciliation | FY2022 Notes to Reconciliation of Adjusted EBITDA 1. Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees. 2. Transaction and integration costs consist of fees incurred
Slide 34: Non-GAAP Reconciliation | 3Q23, 2Q23, 3Q22
Non-GAAP Reconciliation | 3Q23, 2Q23, 3Q 22 © 2023 Modivcare® Inc. 34
Slide 35: Non-GAAP Reconciliation | FY2021
Non-GAAP Reconciliation | FY2021 Notes to Reconciliation of Adjusted EBITDA 1. Restructuring and related costs include professional fees for strategic initiatives and severance and office closure costs. 2. Transaction and integration costs consist of fees incurred in the acquisitions of Care Finders
Slide 36: Non-GAAP Reconciliation | Segments
Non-GAAP Reconciliation | Segments NEMT Segment PCS Segment RPM Segment Reconciliation of Non-GAAP Financial Measures Reconciliation of Non-GAAP Financial Measures Reconciliation of Non-GAAP Financial Measures Twelve Months Twelve Months Twelve Months Ended Sep 30, Ended Sep 30, Ended Sep 30, (dolla